JP2024510504A5 - - Google Patents
Info
- Publication number
- JP2024510504A5 JP2024510504A5 JP2023557370A JP2023557370A JP2024510504A5 JP 2024510504 A5 JP2024510504 A5 JP 2024510504A5 JP 2023557370 A JP2023557370 A JP 2023557370A JP 2023557370 A JP2023557370 A JP 2023557370A JP 2024510504 A5 JP2024510504 A5 JP 2024510504A5
- Authority
- JP
- Japan
- Prior art keywords
- independently selected
- nitrogen
- sulfur
- oxygen
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163162483P | 2021-03-17 | 2021-03-17 | |
| US63/162,483 | 2021-03-17 | ||
| PCT/US2022/020527 WO2022197789A1 (en) | 2021-03-17 | 2022-03-16 | Polycyclic inhibitors of plasma kallikrein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024510504A JP2024510504A (ja) | 2024-03-07 |
| JP2024510504A5 true JP2024510504A5 (enExample) | 2025-03-25 |
Family
ID=81328648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023557370A Pending JP2024510504A (ja) | 2021-03-17 | 2022-03-16 | 血漿カリクレインの多環式インヒビター |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240199613A1 (enExample) |
| EP (1) | EP4308564A1 (enExample) |
| JP (1) | JP2024510504A (enExample) |
| CN (1) | CN117355523A (enExample) |
| WO (1) | WO2022197789A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3765459A1 (en) | 2018-03-13 | 2021-01-20 | Shire Human Genetic Therapies, Inc. | Substituted imidazopyridines as inhibitors of plasma kallikrein and uses thereof |
| EP4031245A1 (en) | 2019-09-18 | 2022-07-27 | Takeda Pharmaceutical Company Limited | Heteroaryl plasma kallikrein inhibitors |
| DK4031547T3 (da) | 2019-09-18 | 2024-09-09 | Takeda Pharmaceuticals Co | Plasmakallikreininhibitorer og anvendelser deraf |
| CN118239959A (zh) * | 2022-12-23 | 2024-06-25 | 上海深势唯思科技有限责任公司 | 环丙烷类tlr7和8抑制剂及其制备方法和用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4911920A (en) | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
| FR2588189B1 (fr) | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
| JP2594486B2 (ja) | 1991-01-15 | 1997-03-26 | アルコン ラボラトリーズ インコーポレイテッド | 局所的眼薬組成物 |
| US5212162A (en) | 1991-03-27 | 1993-05-18 | Alcon Laboratories, Inc. | Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
| US6309853B1 (en) | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| US6989385B2 (en) * | 2000-12-21 | 2006-01-24 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| EP1750715A1 (en) * | 2004-06-04 | 2007-02-14 | Icos Corporation | Methods for treating mast cell disorders |
| KR20080080584A (ko) * | 2005-11-30 | 2008-09-04 | 버텍스 파마슈티칼스 인코포레이티드 | ｃ-Ｍｅｔ의 억제제 및 이의 용도 |
| WO2013052526A1 (en) * | 2011-10-06 | 2013-04-11 | Merck Sharp & Dohme Corp. | Triazolyl pde10 inhibitors |
| JP6280546B2 (ja) * | 2012-06-26 | 2018-02-14 | デル マー ファーマシューティカルズ | ジアンヒドロガラクチトール、ジアセチルジアンヒドロガラクチトール、ジブロモズルシトール、又はこれらの類似体若しくは誘導体を用いた、遺伝子多型又はａｈｉ１の調節不全若しくは変異を有する患者におけるチロシンキナーゼインヒビター抵抗性悪性腫瘍を処置するための方法 |
| CN104059069B (zh) * | 2013-08-22 | 2016-08-10 | 北京康立生医药技术开发有限公司 | 一种替卡格雷的制备方法 |
| EP3134408B1 (en) * | 2014-04-22 | 2020-08-12 | Merck Sharp & Dohme Corp. | FACTOR XIa INHIBITORS |
| EP3765459A1 (en) * | 2018-03-13 | 2021-01-20 | Shire Human Genetic Therapies, Inc. | Substituted imidazopyridines as inhibitors of plasma kallikrein and uses thereof |
-
2022
- 2022-03-16 US US18/550,486 patent/US20240199613A1/en active Pending
- 2022-03-16 WO PCT/US2022/020527 patent/WO2022197789A1/en not_active Ceased
- 2022-03-16 CN CN202280033914.0A patent/CN117355523A/zh active Pending
- 2022-03-16 JP JP2023557370A patent/JP2024510504A/ja active Pending
- 2022-03-16 EP EP22715248.5A patent/EP4308564A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024510504A5 (enExample) | ||
| TW536534B (en) | Difluoroprostaglandin derivatives and pharmaceutical composition comprising them | |
| JP2024516073A5 (enExample) | ||
| JP5596680B2 (ja) | 経口抗がん製剤 | |
| JP2023518286A5 (enExample) | ||
| JP2024510503A5 (enExample) | ||
| JP2005508967A5 (enExample) | ||
| JP2020525442A5 (enExample) | ||
| JP2020510010A5 (enExample) | ||
| JP2018504437A5 (enExample) | ||
| PT2688873E (pt) | Compostos de bis(fluoroalquil)-1,4-benzodiazepinona | |
| RU2016115934A (ru) | Конденсированное гетероциклическое соединение, способ его получения, его фармацевтическая композиция и применения | |
| RU2005137360A (ru) | Органические соединения | |
| EA009985B1 (ru) | Новый способ получения рофлумиласта | |
| JP2024512497A5 (enExample) | ||
| JP2024510502A5 (enExample) | ||
| JP2021512132A (ja) | 置換イミダゾールカルボン酸エステル系誘導体およびその使用 | |
| JP2011520858A (ja) | 置換キナゾリン | |
| JP2025527291A5 (enExample) | ||
| CN114286823B (zh) | 一种光学活性2-羟基四氢噻吩并吡啶类衍生物及其制备方法和用途 | |
| ES2753874T3 (es) | Cristales de solvato novedosos | |
| JPWO2024177126A5 (enExample) | ||
| JP6864299B2 (ja) | 新規なプロスタグランジン誘導体 | |
| EA032872B1 (ru) | Макроциклические ингибиторы rip2-киназы | |
| JPS59204189A (ja) | ジヒドロピリジル環状イミデ−トエステル |